Group One Trading
NBRV

Group One Trading’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Group One Trading’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-316
Closed -$5K – 9186
2021
Q4 		$5K Sell
316
-340
-52% -$8.05K ﹤0.01% 7679
2021
Q3 		$20K Sell
656
-92
-12% -$2.6K ﹤0.01% 7193
2021
Q2 		$25K Buy
748
+656
+713% +$24.4K ﹤0.01% 7065
2021
Q1 		$4K Buy
92
+4
+5% +$249 ﹤0.01% 7320
2020
Q4 		$5K Buy
88
+79
+878% +$8.56K ﹤0.01% 6071
2020
Q3 		$1K Buy
9
+1
+13% +$167 ﹤0.01% 6001
2020
Q2 		$1K Sell
8
-37
-82% -$6.17K ﹤0.01% 5705
2020
Q1 		$7K Sell
45
-10
-18% -$3.06K ﹤0.01% 4712
2019
Q4 		$18K Buy
55
+16
+41% +$7.34K ﹤0.01% 4403
2019
Q3 		$20K Sell
39
-12
-24% -$6.77K ﹤0.01% 4349
2019
Q2 		$31K Buy
+51
New +$31.3K ﹤0.01% 4013
2018
Q4 		– Sell
-4
Closed -$3K – 5695
2018
Q3 		$3K Sell
4
-1
-20% -$709 ﹤0.01% 4991
2018
Q2 		$5K Sell
5
-4
-44% -$4.58K ﹤0.01% 4827
2018
Q1 		$11K Buy
9
+1
+13% +$1.48K ﹤0.01% 4306
2017
Q4 		$13K Buy
+8
New +$12.7K ﹤0.01% 4310

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Group One Trading's NBRV Position: Q1 2022 in Review

Group One Trading sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2022, closing a stake of 967 shares — an estimated $11.8K sold.

Group One Trading first reported a position in NBRV in Q2 2018 and held it in 7 quarters. The position peaked at $100K in Q1 2021. 29 funds tracked by Wall St. Rank hold NBRV as of Q1 2022.

  • Group One Trading reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2022 after selling out during the quarter.
  • Group One Trading sold 967 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2022, an estimated $11.8K.
  • Group One Trading first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2018 and held it in 7 quarters.
  • Group One Trading's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $100K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2022.

Based on Group One Trading's 13F filing for Q1 2022, filed 12 May 2022.